Understanding how small cell lung cancer develops to find new treatments
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
This study is looking into how small cell lung cancer develops and changes, with the goal of finding better treatments to help patients feel better and live longer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10911215 on NIH RePORTER |
What this research studies
This research investigates the molecular and cellular mechanisms that lead to the development of small cell lung cancer (SCLC), a highly aggressive form of lung cancer. The team utilizes innovative techniques to study how cancer cells evolve and respond to treatments, focusing on the role of the retinoblastoma tumor suppressor gene. By examining these processes in detail, the researchers aim to uncover new therapeutic strategies that could improve patient outcomes. The study involves collaboration with various experts and employs advanced models to better understand SCLC biology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with small cell lung cancer, particularly those with Rb mutations.
Not a fit: Patients with other types of lung cancer or those without small cell lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel therapies that significantly improve survival rates for patients with small cell lung cancer.
How similar studies have performed: Previous research has shown promising results in understanding cancer mechanisms, but this approach to SCLC is relatively novel and untested.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Sage, Julien — Stanford University
- Study coordinator: Sage, Julien
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.